MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymphoma, as well as in Phase Ib multi-arm trial to treat B-cell malignancies; and Voruciclib, an oral cyclin-dependent kinase 9 inhibitor, which is in Phase Ib clinical trial for acute myeloid leukemia and B-cell malignancies. It also develops ME-344, a mitochondrial inhibitor targeting the oxidative phosphorylation complex that is in Phase I clinical trial for the treatment of human epidermal growth factor receptor 2 negative breast cancer; and Pracinostat, an oral available histone deacetylase inhibitor, which is in Phase II clinical trial to treat patients with myelodysplastic syndrome. MEI Pharma, Inc. has a license, development, and commercialization agreement with Kyowa Kirin Company; a clinical collaboration with BeiGene, Ltd.; a license, development, manufacturing, and commercialization agreement with Helsinn Healthcare SA; and a license agreement with Presage Biosciences, Inc. The company was formerly known as Marshall Edwards, Inc. and changed its name to MEI Pharma, Inc. in July 2012. MEI Pharma, Inc. was incorporated in 2000 and is headquartered in San Diego, California. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of MEI Pharma Inc..
MEI Pharma Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of MEI Pharma Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of MEI Pharma Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of MEI Pharma Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of MEI Pharma Inc. and all latest updates of the company are provided.
The 2025 version of MEI Pharma Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 MEI Pharma Inc.- Key Facts
2.2 MEI Pharma Inc.- Geographic Locations
2.3 MEI Pharma Inc.- Subsidiaries and Affiliates
2.4 MEI Pharma Inc.- Business Divisions
2.5 MEI Pharma Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. MEI Pharma Inc. Strategic Analysis Review
3.1 MEI Pharma Inc.- Key Strategies
3.2 MEI Pharma Inc.- Company Outlook Statement
3.3 MEI Pharma Inc.- SWOT Analysis
3.3.1 MEI Pharma Inc.- Key Strengths
3.3.2 MEI Pharma Inc.- Key Weaknesses
3.3.3 MEI Pharma Inc.- Potential Opportunities
3.3.4 MEI Pharma Inc.- Potential Threats
3.4 MEI Pharma Inc.- Key Competitors
4. Business Description of the Company
4.1 MEI Pharma Inc.- Business Overview
4.2 MEI Pharma Inc.- Operations by Segment
5 Products and Services Details
5.1 MEI Pharma Inc.- Key Products
5.2 MEI Pharma Inc.- Key Service Areas
5.3 MEI Pharma Inc.- Key Brands
6 Company Developments
6.1 MEI Pharma Inc.- Company History
6.2 MEI Pharma Inc.- Latest Developments
7 Financial Analysis
7.1 MEI Pharma Inc.- Income Statements
7.2 MEI Pharma Inc.- Balance Sheet
7.3 MEI Pharma Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 MEI Pharma Inc.- Direct Competitors
8.2 MEI Pharma Inc.- Competitor Financial Ratios comparison
8.3 MEI Pharma Inc.- Competitor Stock Charts Comparison
8.4 MEI Pharma Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
Get Free Sample
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Why Request a Free Sample?
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
FAQ's
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!
Reach Out to Us
Industries
Resources
Company
Sign up for Offers & Promotions
- Connect with us
- +91 630 95 25755
- sales@swotreports.com
-
Chat on WhatsApp
